Tealwood Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,143
Closed -$1.33M 131
2025
Q1
$1.33M Buy
19,143
+4,807
+34% +$334K 0.62% 77
2024
Q4
$1.23M Buy
14,336
+220
+2% +$18.9K 0.51% 98
2024
Q3
$1.68M Buy
14,116
+116
+0.8% +$13.8K 0.74% 60
2024
Q2
$2M Sell
14,000
-77
-0.5% -$11K 1.2% 37
2024
Q1
$1.81M Sell
14,077
-8,297
-37% -$1.07M 0.81% 50
2023
Q4
$2.32M Sell
22,374
-688
-3% -$71.2K 1.11% 25
2023
Q3
$2.1M Sell
23,062
-202
-0.9% -$18.4K 1.08% 25
2023
Q2
$1.88M Sell
23,264
-332
-1% -$26.9K 0.91% 39
2023
Q1
$1.88M Sell
23,596
-962
-4% -$76.6K 0.96% 34
2022
Q4
$1.66M Sell
24,558
-702
-3% -$47.5K 0.87% 35
2022
Q3
$1.26M Sell
25,260
-58
-0.2% -$2.89K 0.68% 60
2022
Q2
$1.41M Sell
25,318
-242
-0.9% -$13.5K 0.7% 52
2022
Q1
$1.42M Buy
25,560
+102
+0.4% +$5.66K 0.6% 68
2021
Q4
$1.43M Buy
+25,458
New +$1.43M 0.57% 82